Abstract: The formulation includes CBD and a PPAR agonist. The PPAR agonist can be an omega-3 based PPAR agonist and more specifically can comprise substantially equal parts DHA and EPA.

Abstract: A method is for use with a treatment regime that includes the exposure of a patient to THC. The method comprises the step of administering Theanine to the patient. The Theanine can be L-Theanine. The treatment regime can involve a plurality of administrations of THC and Theanine can be administered with each administration of THC. The method of administration can be such that the peak bioavailability of THC occurs substantially contemporaneously with the peak bioavailability of Theanine. A consumer package can be adapted for carrying out the method.

Abstract: The device relates to physical exercise apparatus providing variable resistance to the user has a weight stack movable along a vertical guide and a carriage movable along another guide, the guides being disposed at a predetermined angle to each other and the carriage and the weight stack being connected to each other through a rigid link. The carriage is movable by the user against a variable force dependent on the position of the weight stack in its guide, the angle between the guides and the weight of the stack.